Spironolactone

Product NDC
53002-1707
11-digit product format
530021707
Labeler code
53002
Product ID
53002-1707_57446208-b1dc-4b64-87ab-11e55b7e7cb4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Spironolactone
Dosage form
TABLET
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA091426
Marketing category
ANDA
Marketing start
2010-08-02
Marketing end
0000-00-00
Substance
SPIRONOLACTONE
Active strength
50 mg/1
Pharmacologic classes
Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
27O7W4T232SPIRONOLACTONE52-01-7SPIRONOLACTONE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
53002-1707-053002170700100 TABLET in 1 BOTTLE (53002-1707-0) 100 tablet2019-01-010000-00-00NoNoCurrent
53002-1707-35300217070330 TABLET in 1 BOTTLE (53002-1707-3) 30 tablet2019-01-010000-00-00NoNoCurrent
53002-1707-65300217070660 TABLET in 1 BOTTLE (53002-1707-6) 60 tablet2019-01-010000-00-00NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
SpironolactoneRPK Pharmaceuticals, Inc.2023-06-07HUMAN PRESCRIPTION DRUG LABEL3